glp-1 obesity drug news today oct 23 2025 The FDA approved a new pill from Eli Lilly on Wednesday. The drug, called Foundayo, is the second GLP-1 weight-loss pill. CBS News' Dr. LaPook has more on the new medication Use of diabetes and anti-obesity

Refreshing, hydrating, and the glow shows up in selfies

Sustainable weight loss requires continuous effort beyond medication, including ongoing lifestyle changes and regular monitoring by healthcare providers

None of these studies revealed any significant differences between the ASD group and the healthy control group, although it is appropriate to be cautious in interpreting negative findings

demonstrated that nano-parthenolide improved survival and intestinal barrier function in septic rats by reducing ROS and apoptosis through 5-HTR2A regulation, outperforming conventional formulations (Guo et al., 2023)

doi: 10.1007/s40257-014-0107-3